Role of Toll‐Like Receptors in Myeloid Neoplasms: Focuses on the Molecular Mechanisms and Clinical Impact on Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia
APMIS · 2025-09 · 133 (9)
DOI: 10.1111/apm.70065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift APMIS, online erschienen am 09.09.2025. Verfasst von Clarissa Brenda Alves Cavalcante und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Cytogenomic Laboratory, Center for Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Ceara, Brazil. Hauptthemen laut MEDLINE: Toll-Like Receptors, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Toll‐like receptors (TLRs) are essential components of the innate immune system, functioning as pattern recognition receptors (PRRs) to detect pathogen‐associated molecular patterns (PAMPs) and damage‐associated molecular patterns (DAMPs). In hematological malignancies, particularly myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML), TLRs influence inflammation, disease progression, and therapeutic response. This review highlights the prognostic relevance of TLR expression, the role of the MyD88 signaling pathway in clonal evolution, and the dual nature of TLR‐mediated immune responses, either promoting antitumor activity or contributing to leukemogenesis. Notably, TLR dysregulation in MDS and AML is associated with poor prognosis and genomic instability, whereas in CML, TLRs contribute to a protective microenvironment via NOD‐like and TNF‐α pathways. Therapeutic strategies targeting TLRs, including agonists and antagonists, show promise in enhancing antitumor responses, especially when combined with agents like purine nucleoside phosphorylase inhibitors. Furthermore, genetic variations in TLR pathways may influence individual susceptibility to infection and cancer progression, reinforcing the relevance of personalized medicine. Overall, this review underscores the need for continued research into TLR modulation as a foundation for innovative therapies in hematologic cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Cytogenomic Laboratory, Center for Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Ceara, Brazil.
- Post-Graduate Program of Pathology, Federal University of Ceara, Fortaleza, Ceara, Brazil.
- Post-Graduate Program in Medical Science, Federal University of Ceara, Fortaleza, Ceara, Brazil.
- Post-Graduate Program of Translational Medicine, Federal University of Ceara, Fortaleza, Ceara, Brazil.
ORCID-Profile: Howard Lopes Ribeiro-Junior
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
Zitieren
APA
Cavalcante, C. B. A., Chaves, A. C., de Oliveira, V. S., de Araújo, M. A. S., Cunha E Silva, T. M., Goes, J. V. C., de Oliveira, R. T. G., Pinheiro, R. F., & Ribeiro-Junior, H. L. (2025). Role of Toll‐Like Receptors in Myeloid Neoplasms: Focuses on the Molecular Mechanisms and Clinical Impact on Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia. APMIS, 133(9). https://doi.org/10.1111/apm.70065
Vancouver
Cavalcante CBA, Chaves AC, de Oliveira VS, de Araújo MAS, Cunha E Silva TM, Goes JVC, et al. Role of Toll‐Like Receptors in Myeloid Neoplasms: Focuses on the Molecular Mechanisms and Clinical Impact on Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia. APMIS. 2025;133(9). doi:10.1111/apm.70065
BibTeX
@article{Cavalcante2025,
author = {Cavalcante, Clarissa Brenda Alves and Chaves, Alessandro Cavalcante and de Oliveira, Vanessa Silva and de Araújo, Maria Amanda Silva and Cunha E Silva, Thayres Marinho and Goes, João Vitor Caetano and de Oliveira, Roberta Taiane Germano and Pinheiro, Ronald Feitosa and Ribeiro-Junior, Howard Lopes},
title = {Role of Toll‐Like Receptors in Myeloid Neoplasms: Focuses on the Molecular Mechanisms and Clinical Impact on Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia},
journal = {APMIS},
year = {2025},
volume = {133},
number = {9},
doi = {10.1111/apm.70065}
}
EUVIMED